Xyzal® (Allergies)

Other available trademarks: Xyzal®, Xazal™, Xozal™, Xusal™, Xuzal™, Xyzall™

In Europe, Xyzal® (levocetirizine) tablets are indicated for the symptomatic treatment of allergic rhinitis, including persistent allergic rhinitis, and chronic idiopathic urticaria in adults and children over six years. Xyzal® oral solution is indicated for the symptomatic treatment of allergic rhinitis, including persistent allergic rhinitis, and chronic idiopathic urticaria in adults and children over two years.

In the US, Xyzal® tablets and oral solution are indicated for:

• the relief of symptoms associated with seasonal and perennial allergic rhinitis
• the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria.

Xyzal® is registered in more than 80 countries in the world.

• SmPC Xyzal® (UK). Sourced from www.medicines.org.uk